VCP
TECH icon

Verus Capital Partners’s Bio-Techne TECH Stock Holding History

Verus Capital Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,224
Closed -$207K – 325
2022
Q1 		$207K Buy
+2,224
New +$229K 0.03% 302
2020
Q1 		$199K Sell
4,200
-200
-5% -$10K 0.06% 194
2019
Q4 		$241K Buy
+4,400
New +$231K 0.08% 205

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Verus Capital Partners's TECH Position: Q2 2022 in Review

Verus Capital Partners sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 2,224 shares — an estimated $207K sold.

Verus Capital Partners first reported a position in TECH in Q4 2019 and held it in 3 quarters. The position peaked at $241K in Q4 2019. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Verus Capital Partners reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
  • Verus Capital Partners sold 2,224 Bio-Techne shares in Q2 2022, an estimated $207K.
  • Verus Capital Partners first reported a position in Bio-Techne in Q4 2019 and held it in 3 quarters.
  • Verus Capital Partners's Bio-Techne position peaked at $241K in Q4 2019.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Verus Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.